Published in Mater Sociomed on January 01, 2011
The significance of the psychosocial factors influence in pathogenesis of cardiovascular disease. Int J Prev Med (2013) 0.97
Clinical Effects of Portulaca Oleracea Seeds on Dyslipidemia in Obese Adolescents: a Triple-blinded Randomized Controlled Trial. Med Arch (2014) 0.77
Modified Algorithm for the Risk of Coronary Heart Disease Estimation. Med Arch (2016) 0.75
Clinical Effects of Rhus coriaria Fruits on Dyslipidemia308 in Adolescents: a Triple-blinded Randomized Placebo-controlled Trial. Med Arch (2014) 0.75
Population Attributable Fraction for Cardiovascular Diseases Risk Factors in Selected Countries: A comparative study. Mater Sociomed (2017) 0.75
Evaluation of Congenital Heart Defects Treatment Options-Establishment of Pediatric Cardiology/Cardiosurgery in Bosnia and Herzegovina. Mater Sociomed (2017) 0.75
Critical Carotid Artery Stenosis in Coronary and Non-Coronary Patients - Frequency of Risk Factors. Med Arch (2017) 0.75
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet (2004) 42.12
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet (2002) 40.37
Selected major risk factors and global and regional burden of disease. Lancet (2002) 24.47
Cardiovascular disease risk profiles. Am Heart J (1991) 21.65
C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med (2004) 15.30
C-reactive protein: a critical update. J Clin Invest (2003) 11.77
A meta-analysis of physical activity in the prevention of coronary heart disease. Am J Epidemiol (1990) 7.24
Mortality in relation to consumption of alcohol: 13 years' observations on male British doctors. BMJ (1994) 6.74
Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J (Clin Res Ed) (1984) 5.79
Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation (1999) 5.62
Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. BMJ (1991) 5.45
Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators. N Engl J Med (1999) 5.09
Trends in cardiovascular complications of diabetes. JAMA (2004) 4.74
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation (2006) 4.61
Associations of general and abdominal obesity with multiple health outcomes in older women: the Iowa Women's Health Study. Arch Intern Med (2000) 4.36
Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J (1994) 4.02
Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. Arteriosclerosis (1990) 4.01
Economic burden of cardiovascular diseases in the enlarged European Union. Eur Heart J (2006) 3.65
Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): resetting the hypertension sails. Hypertension (2003) 3.18
Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association. Circulation (1998) 3.18
Framingham risk score and prediction of lifetime risk for coronary heart disease. Am J Cardiol (2004) 2.89
The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur Heart J (1997) 2.72
Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation (1999) 2.50
C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Circulation (2004) 2.43
Drinking frequency, mediating biomarkers, and risk of myocardial infarction in women and men. Circulation (2005) 2.29
The epidemiology of coronary heart disease. A review. J Chronic Dis (1965) 2.19
Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum. Circulation (2004) 2.16
Using the Framingham model to predict heart disease in the United Kingdom: retrospective study. BMJ (2000) 2.02
Risk assessment in primary prevention of coronary heart disease: randomised comparison of three scoring methods. BMJ (2000) 1.92
Dynamics of cardiovascular and all-cause mortality in Western and Eastern Europe between 1970 and 2000. Eur Heart J (2005) 1.91
Hostility and increased risk of mortality and acute myocardial infarction: the mediating role of behavioral risk factors. Am J Epidemiol (1997) 1.89
Trends in cardiovascular diseases in Bosnia and Herzegovina and perspectives with heartscore programme. Med Arh (2010) 1.71
The problem of tobacco smoking. BMJ (2004) 1.60
Screening for early detection of cardiovascular disease in asymptomatic individuals. Am Heart J (2003) 1.58
Silent myocardial ischemia. Is the person or the event silent? JAMA (1990) 1.54
Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S). Am J Cardiol (1998) 1.32
Estimating cardiovascular risk for primary prevention: outstanding questions for primary care. BMJ (2000) 1.24
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the population science discussion group. Circulation (2004) 1.13
The value of C-reactive protein in cardiovascular risk prediction: the Rotterdam Study. Arch Intern Med (2003) 1.04
Prevention of chronic diseases: WHO global strategy on diet, physical activity and health. Food Nutr Bull (2003) 0.96
Insulin resistance, obesity and hypertension. J Nutr (1995) 0.79
Exposure to environmental tobacco smoke and coronary risk. Circulation (1997) 0.78
Epidemiology and interaction of risk factors in cardiovascular disease. Prim Care (1989) 0.77
Statins and stroke. Therapie (2003) 0.77
Trends in cardiovascular diseases in Bosnia and Herzegovina and perspectives with heartscore programme. Med Arh (2010) 1.71
Social networks in improvement of health care. Mater Sociomed (2012) 1.39
Distance learning at biomedical faculties in bosnia & herzegovina. Stud Health Technol Inform (2005) 1.20
Information Technologies (ITs) in Medical Education. Acta Inform Med (2011) 1.13
Why historians of medicine called Ibn al-Nafis second Avicenna? Med Arh (2008) 1.09
Family Registration Card as electronic medical carrier in Bosnia and Herzegovina. Med Arh (2004) 0.97
Clinical, echocardiographic and echophonocardiographic characteristics of the atrial myxomas in 22 years period. Med Arh (2009) 0.86
Medical education and role of medical informatics. Stud Health Technol Inform (2006) 0.85
Epidemiology features of brucellosis at the Zenica-Doboj Canton area in period 2000-2007. Med Arh (2008) 0.78
The advantages and limitations of international classification of diseases, injuries and causes of death from aspect of existing health care system of bosnia and herzegovina. Acta Inform Med (2008) 0.77
Left bundle branch block (LBBB) in patients with heart failure (HF) in Mostar region of Bosnia and Herzegovina. Med Arh (2007) 0.75
Primary percutaneous coronary interventions network in Bosnia and Herzegovina--Sarajevo's proposal. Med Arh (2010) 0.75
Fostering diffusion of scientific contents of national society cardiovascular journals: the new ESC search engine. Med Arch (2013) 0.75
Data Sharing: A New Editorial Initiative of the International Committee of Medical Journal Editors. Implications for the Editors´ Network. Turk Kardiyol Dern Ars (2017) 0.75
The role of exercise test in stratifying the risk of asymptomatic patients with moderate/severe aortic stenosis. Med Arh (2010) 0.75
Data Sharing: A New Editorial Initiative of the International Committee of Medical Journal Editors. Implications for the Editors' Network. Kardiol Pol (2017) 0.75
Analysis of the electroencephalogram and pain characteristic in patients before and after carbamazepine treatment. Med Arh (2008) 0.75